Alabama Licensed Builder Brings Physical Home Sale Directly to Ethereum Blockchain
Affordable Home U.S. LLC, a licensed residential home builder in Alabama, announced the upcoming sale of a newly constructed home using its deployed ERC-20 utility token, Affordable Home Token (AHOME).
The company has already purchased the land for the first home sale, finalized architectural plans for a 1,200-square-foot high-performance energy-efficient residence, and launched a public decentralized application (dApp) at AffordableHomeToken.com that allows users to interact directly with audited smart contracts deployed on the Ethereum blockchain.
The smart-contract system supporting the token and auction process has been independently audited by QuillAudits, and the token contract is publicly verified on blockchain explorers.
Participants will be able to acquire AHOME tokens through a planned public fair-launch auction using Gnosis EasyAuction on Ethereum, followed by additional token availability through a Uniswap decentralized exchange liquidity pool. Anyone capable of obtaining Ethereum and using a Web3 wallet such as MetaMask will be able to participate.
Holding AHOME tokens provides direct utility — token holders can connect their wallet to the project dApp and use tokens to reserve a newly constructed home within the builder’s development pipeline.
Upon completion of construction, the home will be transferred through standard off-chain real estate closing procedures, including title transfer, deed recording, and required tax documentation. At that time, the corresponding AHOME tokens used for the reservation will be permanently removed from circulation.
Affordable Home U.S. holds Alabama Unlimited Home Builder License #29303, maintains $2 million in general liability coverage, and is BBB accredited. The company operates multiple construction and home-service brands across Alabama, including Bama Waterproofing, and has established experience in residential construction execution.
The initiative introduces direct blockchain utility tied to a fundamental real-world need — housing. By bringing physical homes for sale onto an open blockchain market, the company aims to expand participation beyond traditional financing pathways.
The company is currently collecting auction waitlist registrations from prospective participants. Interested individuals may join the waitlist by submitting their email and indicating their anticipated auction participation level.
Auction timing will be finalized based on demonstrated market interest.
Affordable Home U.S. LLC
Birmingham, Alabama
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
Crypto prices
More
